Vismodegib Effective Against Skin Cancer in Patients With Basal-Cell Nevus Syndrome
August 31st 2012The oral hedgehog pathway inhibitor vismodegib is effective for both the prevention and treatment of basal-cell carcinoma in patients with the rare disorder known as basal-cell nevus syndrome.
Read More
Lenalidomide Maintenance After Stem-Cell Transplantation Benefits Patients With Multiple Myeloma
August 31st 2012Lenalidomide used continuously after autologous hematopoietic stem cell transplantation significantly prolonged the time to disease progression and overall survival in patients with multiple myeloma.
Read More